Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Stover

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
American Journal of Human Genetics|September 13, 2024
Germline polygenic risk scores are associated with immune gene expression signature and immune cell infiltration in breast cancerYuxi Liu, Cheng Peng, Ina S Brorson, et al.
European Journal of Breast Health|July 14, 2020
Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female ControlsJoseph Liu, Anupama Suresh, Marilly Palettas, et al.
Psychoneuroendocrinology|March 22, 2025
The role of oxytocin in mediating the relationships between social factors and chemotherapy-associated cognitive decline in female patients with breast cancerMelina M Seng, Seth Adarkwah Yiadom, Lauren D Otto-Dobos, et al.
Pain|March 21, 2023
Conflicts hurt: social stress predicts elevated pain and sadness after mild inflammatory increasesAnnelise A Madison, Megan Renna, Rebecca Andridge, et al.
NPJ Breast Cancer|May 16, 2018
Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancerDaniel G Stover, Carlos R Gil Del Alcazar, Jane Brock, et al.
Breast Cancer Research and Treatment|September 9, 2021
Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancerJasmine S Sukumar, Dionisia Quiroga, Mahmoud Kassem, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trialKe-Da Yu, Xi-Yu Liu, Li Chen, et al.
Cancer|September 11, 2023
Turning the Page on Breast Cancer in Ohio: Lessons learned from implementing a multilevel intervention to reduce breast cancer mortality among Black womenTasleem J Padamsee, Daniel G Stover, Willi L Tarver, et al.
Breast Cancer Research : BCR|November 15, 2022
Association of body mass index and inflammatory dietary pattern with breast cancer pathologic and genomic immunophenotype in the nurses' health studySarah Asad, Adrienne Damicis, Yujing J Heng, et al.
Lymphatic Research and Biology|December 3, 2025
Using Group Concept Mapping to Define Priorities for Lymphedema Care and ResearchSara P Myers, Min-Jeong Cho, Erin E Burke, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
American Journal of Human Genetics|September 13, 2024
Germline polygenic risk scores are associated with immune gene expression signature and immune cell infiltration in breast cancerYuxi Liu, Cheng Peng, Ina S Brorson, et al.
European Journal of Breast Health|July 14, 2020
Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female ControlsJoseph Liu, Anupama Suresh, Marilly Palettas, et al.
Psychoneuroendocrinology|March 22, 2025
The role of oxytocin in mediating the relationships between social factors and chemotherapy-associated cognitive decline in female patients with breast cancerMelina M Seng, Seth Adarkwah Yiadom, Lauren D Otto-Dobos, et al.
Pain|March 21, 2023
Conflicts hurt: social stress predicts elevated pain and sadness after mild inflammatory increasesAnnelise A Madison, Megan Renna, Rebecca Andridge, et al.
NPJ Breast Cancer|May 16, 2018
Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancerDaniel G Stover, Carlos R Gil Del Alcazar, Jane Brock, et al.
Breast Cancer Research and Treatment|September 9, 2021
Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancerJasmine S Sukumar, Dionisia Quiroga, Mahmoud Kassem, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trialKe-Da Yu, Xi-Yu Liu, Li Chen, et al.
Cancer|September 11, 2023
Turning the Page on Breast Cancer in Ohio: Lessons learned from implementing a multilevel intervention to reduce breast cancer mortality among Black womenTasleem J Padamsee, Daniel G Stover, Willi L Tarver, et al.
Breast Cancer Research : BCR|November 15, 2022
Association of body mass index and inflammatory dietary pattern with breast cancer pathologic and genomic immunophenotype in the nurses' health studySarah Asad, Adrienne Damicis, Yujing J Heng, et al.
Lymphatic Research and Biology|December 3, 2025
Using Group Concept Mapping to Define Priorities for Lymphedema Care and ResearchSara P Myers, Min-Jeong Cho, Erin E Burke, et al.
Pageof 15